Medical management of glaucoma.
D000208:Acute Disease; D002217:Carbachol / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D002648:Child; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D002908:Chronic Disease; D064420:Drug-Related Side Effects and Adverse Reactions; D004837:Epinephrine / Q000627:therapeutic use; D005901:Glaucoma / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D008353:Mannitol / Q000627:therapeutic use; D009020:Morphine / Q000627:therapeutic use; D010830:Physostigmine / Q000627:therapeutic use; D010862:Pilocarpine / Q000627:therapeutic use; D014065:Tonometry, Ocular
D002257:Carbonic Anhydrase Inhibitors; D002800:Cholinesterase Inhibitors; D010862:Pilocarpine; D008353:Mannitol; D009020:Morphine; D002217:Carbachol; D010830:Physostigmine; D004837:Epinephrine; D006145:Guanethidine